Li Tianfeng T - OmicsDI

Show results for

Metabolomics (2)
Proteomics (1)

Organisms

Drosophila melanogaster (1)

Repository

MetaboLights (2)
iProX (1)

Technology Type

Mass spectrometry (1)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2025 (2)
2024 (1)

Metabolite Name

(+)-(1R,2R)-1,2-Diphenylethane-1,2-diol (1)
(+)-1(10),4-Cadinadiene (1)
(+)-1(9),10-Pacifigorgiadiene (1)
(+)-1-Methylpropyl 3-(methylthio)-2-propenyl disulfide (1)
(+)-11-Hydroxy-9-triacontanone (1)
(+)-12a-Hydroxypachyrrhizone (1)
(+)-15,16-Dihydroxyoctadecanoic acid (1)
(+)-2,3-Dihydro-3-methyl-1H-pyrrole (1)
(+)-3-(3,4-Methylenedioxyphenyl)-1,2-propanediol (1)
(+)-4,11-Eudesmadien-3-one (1)
(+)-7-epi-Syringaresinol 4'-glucoside (1)
(+)-Borneol (1)
(+)-Calycanthine (1)
(+)-Erysotrine (1)
(+)-Erythraline (1)
(+)-Isoborneol (1)
(+)-Isomenthone (1)
(+)-Isoxanthochymol (1)
(+)-Ledene (1)
(+)-Menthone (1)
(+)-Myrtenyl formate (1)
(+)-Neoisomenthol (1)
(+)-Neomenthol (1)
(+)-O-Methylarmepavine (1)
(+)-Quebrachidine (1)
(+)-Zeylenol (1)
(+)-alpha-Bisabolol (1)
(+)-alpha-Muurolene (1)
(+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one (1)
(+)-threo-2-Amino-3,4-dihydroxybutanoic acid (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

The effect of an NAT10 inhibitor (remodelin) on inflammation-related genes in the treatment of thalamic hemorrhage based on metabolic data

Thalamic hemorrhage is a disease caused by hemorrhage of the thalamic brain parenchyma and is accompanied by an inflammatory response during development. NAT10 has been associated with a wide range of diseases. The aim of this study was to explore the molecular mechanisms associated with the use ...

2025-11-13 | MTBLS11941 | MetaboLights

Drosophila tracheal cell mass spectrum data

Proteomics of the trachea surface of third instar Drosophila larvae

ORGANISM(S): Drosophila Melanogaster

2024-02-02 | PXD049142 |

Sensing Ceramides by CYSLTR2 and P2RY6 to Aggravate Atherosclerosis

Recent evidence shows elevated circulating long-chain ceramide levels predicts atherosclerotic cardiovascular disease (ASCVD) independently of cholesterol. Although targeting ceramides signaling may provide therapeutic benefits beyond the treatment of hypercholesterolemia, the underlying mechanis...

2025-04-15 | MTBLS11925 | MetaboLights

Previous page
1 / 1
You're on page 1
Next page